RB Capital Management LLC Takes $1.11 Million Position in HCA Healthcare, Inc. $HCA

Posted by Brian Himes on Aug 29th, 2026

RB Capital Management LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 2,860 shares of the company’s stock, valued at approximately $1,115,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at $1,021,000. NewEdge Advisors LLC lifted its position in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC boosted its stake in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the period. Jump Financial LLC purchased a new position in HCA Healthcare in the second quarter valued at about $2,073,000. Finally, Sei Investments Co. raised its position in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after acquiring an additional 49,214 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 0.4%

Shares of HCA stock opened at $417.57 on Friday. The company has a market capitalization of $90.40 billion, a P/E ratio of 13.98, a P/E/G ratio of 1.46 and a beta of 1.10. The firm has a 50-day moving average price of $401.08 and a 200 day moving average price of $441.46. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the previous year, the business earned $6.84 EPS. HCA Healthcare’s revenue was up 8.7% compared to the same quarter last year. As a group, research analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HCA. The Goldman Sachs Group dropped their price target on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research report on Tuesday, July 28th. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 7th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research report on Monday, August 3rd. Truist Financial lowered their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research note on Monday, July 27th. Finally, Morgan Stanley reduced their target price on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research note on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $462.64.

Check Out Our Latest Stock Report on HCA Healthcare

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.